Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.01% atropine eye drops for myopia inhibition in children and adolescents
DRKS00020585Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Feb 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of atropine in myopia and disorders of accommodation, sponsored by University Hospital Tübingen. Started Feb 2020; status: completed.
02
Drugs
atropine
03
Conditions
myopiadisorders of accommodation
Beyond the preview
Go deeper on DRKS00020585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00020585.